About Neutrophil collagenase
Neutrophil collagenase (MMP8) is a protein
from Homo sapiens identified by UniProt accession
P22894, 467 residues long.
MolForge cross-references it against 0 known binders and
612 disease associations.
Target properties
| Protein name | Neutrophil collagenase |
| UniProt accession | P22894 |
| Gene | MMP8 |
| Organism | Homo sapiens |
| Length | 467 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (3)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (612)
Diseases linked to this target (Open Targets).
- acne · score 0.61
- periodontitis · score 0.60
- rosacea · score 0.59
- Helicobacter pylori infectious disease · score 0.59
- infection · score 0.59
- COVID-19 · score 0.58
- chronic obstructive pulmonary disease · score 0.58
- Lyme disease · score 0.57
- Borrelia infectious disease · score 0.56
- Chlamydia trachomatis infectious disease · score 0.55
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P22894-F1 | alphafold | PREDICTED | 90.37 | — |
Amino-acid sequence (467 residues)
MFSLKTLPFL LLLHVQISKA FPVSSKEKNT KTVQDYLEKF YQLPSNQYQS TRKNGTNVIV EKLKEMQRFF GLNVTGKPNE ETLDMMKKPR CGVPDSGGFM LTPGNPKWER TNLTYRIRNY TPQLSEAEVE RAIKDAFELW SVASPLIFTR ISQGEADINI AFYQRDHGDN SPFDGPNGIL AHAFQPGQGI GGDAHFDAEE TWTNTSANYN LFLVAAHEFG HSLGLAHSSD PGALMYPNYA FRETSNYSLP QDDIDGIQAI YGLSSNPIQP TGPSTPKPCD PSLTFDAITT LRGEILFFKD RYFWRRHPQL QRVEMNFISL FWPSLPTGIQ AAYEDFDRDL IFLFKGNQYW ALSGYDILQG YPKDISNYGF PSSVQAIDAA VFYRSKTYFF VNDQFWRYDN QRQFMEPGYP KSISGAFPGI ESKVDAVFQQ EHFFHVFSGP RYYAFDLIAQ RVTRVARGNK WLNCRYG
Explore Neutrophil collagenase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets